Gabelli Healthcare Wellnessrx Stock Performance
| GRX Stock | USD 9.78 0.01 0.10% |
The company retains a Market Volatility (i.e., Beta) of 0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Gabelli Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Gabelli Healthcare is expected to be smaller as well. At this point, Gabelli Healthcare has a negative expected return of -0.12%. Please make sure to check out Gabelli Healthcare's treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Gabelli Healthcare performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Gabelli Healthcare WellnessRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return (0.10) | Five Day Return 2.62 | Year To Date Return 1.24 | Ten Year Return (6.86) | All Time Return 19.27 |
Forward Dividend Yield 0.0743 | Payout Ratio | Last Split Factor 1035:1000 | Forward Dividend Rate 0.6 | Dividend Date 2018-12-14 |
1 | Acquisition by Saba Capital Management, L.p. of 10441 shares of Gabelli Healthcare at 10.59 subject to Rule 16b-3 | 10/24/2024 |
2 | Disposition of tradable shares by Jeffrey Jonas of Gabelli Healthcare subject to Rule 16b-3 | 11/01/2024 |
3 | Acquisition by Saba Capital Management, L.p. of 5364 shares of Gabelli Healthcare at 10.36 subject to Rule 16b-3 | 11/11/2024 |
4 | Acquisition by James Conn of 8362 shares of Gabelli Healthcare at 9.0 subject to Rule 16b-3 | 11/13/2024 |
5 | Acquisition by Mario Gabelli of 4000 shares of Gabelli Healthcare at 10.14 subject to Rule 16b-3 | 11/21/2024 |
6 | Acquisition by Saba Capital Management, L.p. of 4876 shares of Gabelli Healthcare at 10.16 subject to Rule 16b-3 | 11/22/2024 |
7 | Acquisition by Saba Capital Management, L.p. of 4341 shares of Gabelli Healthcare at 10.24 subject to Rule 16b-3 | 11/25/2024 |
8 | Acquisition by Saba Capital Management, L.p. of 2869 shares of Gabelli Healthcare at 10.42 subject to Rule 16b-3 | 11/27/2024 |
9 | Gabelli buys 1,154 in Gabelli healthcare wellnessrx trust shares | 12/02/2024 |
10 | Acquisition by Mario Gabelli of 7863 shares of Gabelli Healthcare at 10.5 subject to Rule 16b-3 | 12/03/2024 |
11 | Sarama Resources Submits Request for Arbitration Against Burkina Faso | 12/11/2024 |
12 | Acquisition by Mario Gabelli of 3456 shares of Gabelli Healthcare at 10.3 subject to Rule 16b-3 | 12/12/2024 |
13 | Acquisition by Mario Gabelli of 544 shares of Gabelli Healthcare at 10.12 subject to Rule 16b-3 | 12/13/2024 |
14 | Gabelli invests over 41,000 in Gabelli Healthcare WellnessRx trust By Investing.com - Investing.com | 12/16/2024 |
15 | Saba capital management acquires Gabelli healthcare stock for 198,773 - Investing.com | 12/19/2024 |
| Gabelli Healthcare dividend paid on 20th of December 2024 | 12/20/2024 |
16 | Acquisition by Mario Gabelli of 4000 shares of Gabelli Healthcare at 9.8 subject to Rule 16b-3 | 12/30/2024 |
17 | Acquisition by Mario Gabelli of 2000 shares of Gabelli Healthcare at 9.7 subject to Rule 16b-3 | 12/31/2024 |
18 | Disposition of 1115 shares by Vanekris Anthonie C of Gabelli Healthcare at 9.65 subject to Rule 16b-3 | 01/08/2025 |
19 | Resources Top 5 FIRB hurdle cleared for EMR potash deal | 01/14/2025 |
| Begin Period Cash Flow | 50.5 K |
Gabelli |
Gabelli Healthcare Relative Risk vs. Return Landscape
If you would invest 1,053 in Gabelli Healthcare WellnessRx on October 20, 2024 and sell it today you would lose (75.00) from holding Gabelli Healthcare WellnessRx or give up 7.12% of portfolio value over 90 days. Gabelli Healthcare WellnessRx is generating negative expected returns assuming volatility of 0.8808% on return distribution over 90 days investment horizon. In other words, 7% of stocks are less volatile than Gabelli, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Gabelli Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gabelli Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Gabelli Healthcare WellnessRx, and traders can use it to determine the average amount a Gabelli Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1309
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GRX |
Estimated Market Risk
| 0.88 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gabelli Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gabelli Healthcare by adding Gabelli Healthcare to a well-diversified portfolio.
Gabelli Healthcare Fundamentals Growth
Gabelli Stock prices reflect investors' perceptions of the future prospects and financial health of Gabelli Healthcare, and Gabelli Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gabelli Stock performance.
| Return On Equity | -13.74 | ||||
| Shares Outstanding | 15.6 M | ||||
| Price To Earning | 4.15 X | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 127.51 X | ||||
| Revenue | 1.24 M | ||||
| EBITDA | 3.2 M | ||||
| Net Income | 422.8 K | ||||
| Total Debt | 53.32 M | ||||
| Cash Flow From Operations | (356.48 K) | ||||
| Earnings Per Share | (0.29) X | ||||
| Market Capitalization | 152.68 M | ||||
| Total Asset | 239.04 M | ||||
| Retained Earnings | 70.47 M | ||||
About Gabelli Healthcare Performance
Evaluating Gabelli Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Gabelli Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Gabelli Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.02 | 0.01 |
Things to note about Gabelli Healthcare performance evaluation
Checking the ongoing alerts about Gabelli Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gabelli Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gabelli Healthcare generated a negative expected return over the last 90 days | |
| Gabelli Healthcare generates negative cash flow from operations | |
| On 20th of December 2024 Gabelli Healthcare paid $ 0.15 per share dividend to its current shareholders | |
| Latest headline from stockhead.com.au: Resources Top 5 FIRB hurdle cleared for EMR potash deal |
- Analyzing Gabelli Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gabelli Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Gabelli Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gabelli Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gabelli Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gabelli Healthcare's stock. These opinions can provide insight into Gabelli Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Gabelli Stock Analysis
When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.